Trans-cellular introduction of HIV-1 protein Nef induces pathogenic response in Caenorhabditis elegans

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Nazir, Aamir ^a   Sammi, Shreesh Raj ^a   Singh, Pankaj ^a   Tripathi, Raj Kamal ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; NILE RED; OXAZINE DERIVATIVE;

ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN IMMUNODEFICIENCY VIRUS 1; INFERTILITY; LIPODYSTROPHY; NEUROMUSCULAR FUNCTION; NEUROTRANSMISSION; NONHUMAN; PROTEIN FUNCTION; VIRUS GENOME; VIRUS REPLICATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; PHENOTYPE; TEMPERATURE; TRANSGENIC MOUSE; VIROLOGY;

CAENORHABDITIS ELEGANS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; MUS MUSCULUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; LIPODYSTROPHY; MICE; MICE, TRANSGENIC; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; OXAZINES; PHENOTYPE; TEMPERATURE;

EID: 78650780701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015312     Document Type: Article

References (53)

1. Wu Y, Marsh JW (2001) Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293: 1503-1506.
2. Garcia JV, Miller AD (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350: 508-511.
3. Schwartz O, Maréchal V, Le Gall S, Lemonnier F, Heard JM (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2: 338-342.
4. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K (1999) Identification of the Nef-associated kinase as p21-activated kinase 2. Current Biology 9: 1407-1410.
5. Sousa AE, Carneiro J, Scellersheim MM, Grossman Z, Victorino RMM (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169: 3400-3406.
6. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC (2001) HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410: 834-838.
7. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G (2002) HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway. Cell 111: 853-866.
8. Hung CH, Thomas L, Ruby CE, Atkins KM, Morris NP, et al. (2007) HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I. Cell Host Microbe 1: 121-133.
9. Atkins KM, Thomas L, Youker RT, Harriff MJ, Pissani F, et al. (2008) HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice. J Biol Chem 283: 11772-11784.
10. Noviello CM, Benichou S, Guatelli JC (2008) Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J Virol 82: 1249-1258.
11. Wonderlich ER, Williams M, Collins KL (2008) The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J Biol Chem 283: 3011-3012.
12. Lindwasser OW, Smith WJ, Chaudhuri R, Yang P, Hurley JH, et al. (2008) A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J Virol 82: 1166-1174.
13. Grzesiek S, Bax A, Hu JS, Tjandra N, Kaufman J, et al. (1997) Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci 6: 1248-1263.
14. Coleman SH, Van Damme N, Day JR, Noviello CM, Hitchin D, et al. (2005) Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes. J Virol 79: 2066-2078.
15. Zheng YH, Plemenitas A, Linnemann T, Fackler OT, Peterlin BM (2001) Nef increases infectivity of HIV via lipid rafts. Curr Biol 11: 875-879.
16. Kirchhoff F, Schindler M, Bailer N, Renkema GH, Saksela K, et al. (2002) Live and let die: Nef functions beyond HIV replication. Immunity 16: 493-497.
17. Rauch S, Pulkkinen K, Saksela K, Fackler (2008) OT Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J Virol 82: 2918-2929.
18. Agopain K, Wei BL, Garcia JV, Gabuzda D (2006) A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J Virol 6: 3050-3061.
19. Pulkkinen K, Renkema GH, Kirchhoff F, Saksela K (2004) Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J Virol 78: 12773-12778.
20. Arora VK, Molina RP, Foster JL, Blakemore JL, Chernoff J, et al. (2000) Lentivirus Nef specifically activates Pak2. J Virol 74: 11081-11087.
21. Raney A, Kuo LS, Baugh LL, Foster JL, Garcia JV (2005) Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex. J Virol 79: 12732-12741.
22. Neill EO, Kuo LS, Krisko JF, Tomchick DR, Garcia JV, et al. (2006) Dynamic Evolution of the Human Immunodeficiency Virus Type 1 Pathogenic Factor, Nef. J Virol 80: 1311-1320.
23. Ye H, Choi HJ, Poe J, Smithgall TE (2004) Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck. Biochemistry 43: 15775-15784.
24. Fackler OT, Baur AS (2002) Live and let die: Nef functions beyond HIV replication. Immunity 16: 493-497.
25. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC (1995) Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332: 228-232.
26. Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, et al. (2007) Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology 4: 1-13.
27. Kestler HWD, Ringler DJ, Mori K, Panicali DL, Sehgal PK, et al. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651-662.
28. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, et al. (1998) Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 in Immune Cells Develop a Severe AIDS-Like Disease. J Virol 72: 121-132.
29. Hanna Z, Priceputu E, Hu C, Vincent P, Jolicoeur P (2006) HIV-1 Nef mutations abrogating downregulation of CD4 affects other Nef functions and show reduced pathogenecity in transgenic mice. Virol 346: 40-52.
30. Artal-Sanz M, de Jong L, Tavernarakis N (2006) Caenorhabditis elegans: a versatile platform for drug discovery. Biotechnol J 1: 1405-1418.
31. Baumeister R, Ge L (2002) The worm in us-Caenorhabditis elegans as a model of human disease. Trends Biotechnol 20: 147-148.
32. Shaham S (2006) Worming into the cell: Viral reproduction in Caenorhabditis elegans. Proc Natl Acad Sci 103: 3955-3956.
33. Liu WH, Lin YL, Wang JP, Liou W, Hou RF, et al. (2006) Restriction of vaccinia virus replication by a ced-3 and ced-4-dependent pathway in Caenorhabditis elegans. Proc Natl Acad Sci 103: 4174-4179.
34. Delom F, Fessart D, Caruso ME, Chevet E (2007) Tat-mediated protein delivery in living Caenorhabditis elegans. Biochem Biophys Res Commun 352: 587-591.
35. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetlcs 77: 71-94.
36. Stiernagle T (1999) Maintenance of C. Elegans In: Hope I. C. elegans: A Practical Approach Oxford University Press. pp 51-67.
37. Duerr JS (2006) Immunohistochemistry In: The C. elegans Research Community. WormBook doi/10.1895/wormbook.1.105.1.
38. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, et al. (2003) Genomewide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268-272.
39. Fackler O, Moris A, Tibroni N, Giese S, Glass B, et al. (2006) Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351: 332-339.
40. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, et al. (1998) Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175.
41. Martínez E, Mocroft A, García-Viejo MA, Pérez-Cuevas JB, Blanco J, et al. (2001) Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. The Lancet 357: 592-598.
42. Balasubramanyam A, Mersmann H, Jahoor F, Phillips TM, Sekhar RV, et al. (2007) Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice. Am J Physiol Endocrinol Metab 292: E40-E48.
43. Brey CW, Nelder MP, Hailemariam T, Gaugler R, Hashmi S (2009) Krüppellike family of transcription factors: an emerging new frontier in fat biology. Int J Biol Sci 5: 622-636.
44. Kimura KD, Tissenbaum HA, Yanxia L, Ruvkun G (1997) Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946.
45. Leibowitz S, Alexander J (1998) Hypothalamic serotonin in control of eating behavior, meal size and body weight. Biol. Psychiatry 44: 851-862.
46. Sze JY, Victor M, Loer C, Shi Y, Ruvkun G (2000) Food and metabolic signaling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 403: 560-564.
47. A Carr (2003) HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 17: S141-S148.
48. Valdés-Ferrer SI, Crispín JC, Belaunzarán PF, Cantú-Brito CG, Sierra-Madero J, et al. (2009) Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. AIDS Res Hum Retroviruses 25: 749-755.
49. Dhawan R, Dusenbery DB, Williams PL (1999) Comparison of lethality, reproduction and behavior as toxicity endpoints in the nematode Caenorhbaditis elegans. J. Toxicol. Environ. Health A58: 451-462.
50. Ruan QL, Ju JJ, Li YH, Liu R, Pu YP, et al. (2009) Evaluation of pesticide toxicities with differing mechanisms using Caenorhabditis elegans. J Toxicol Environ Health 72: 746-751.
51. Zhang J, Yang C, Brey C, Rodriguez M, Oksov Y, et al. (2009) Mutation in Caenorhabditis elegans Krüppel-like factor, KLF-3 results in fat accumulation and alters fatty acid composition. Exp Cell Res 315: 2568-2580.
52. Bell R, Hubbard A, Chettier R, Chen D, Miller JP, et al. (2009) A human protein interaction network shows conservation of aging processes between human and invertebrate species. PLoS Genet 5: e1000414.
53. Betzi S, Restouin A, Opi S, Arold ST, Parrot I, et al. (2007) Protein protein interaction inhibition (2P2I). combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Proc Natl Acad Sci 104: 19256-19261.